Quick Answer
FRACTYL HEALTH, INC. reported Cash and Equivalents of $81.54 million for fiscal year 2025.
FRACTYL HEALTH, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $81.54M | +20.9% |
| 2024 | $67.46M | +103.1% |
| 2023 | $33.21M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $77.66M | -8.3% | +248.4% |
| June 30, 2025 | $22.29M | -78.2% | -47.1% |
| March 31, 2025 | $42.11M | -65.3% | -37.6% |
| December 31, 2024 | $67.46M | +103.1% | -20.3% |
| September 30, 2024 | $84.66M | — | -17.4% |
| June 30, 2024 | $102.44M | — | -15.6% |
| March 31, 2024 | $121.44M | — | +265.7% |
| December 31, 2023 | $33.21M | — | — |
- FRACTYL HEALTH, INC. showed an increase of +20.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, FRACTYL HEALTH, INC.’s cash and equivalents has grown by 145.5% (from $33.21 million to $81.54 million).
- The most recent figure is from FRACTYL HEALTH, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: